Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-062992
Filing Date
2022-03-02
Accepted
2022-03-02 16:16:59
Documents
2
Group Members
JOSEPH EDELMANPERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G d320860dsc13g.htm SC 13G 59028
2 EX-1 d320860dex1.htm EX-1 4268
  Complete submission text file 0001193125-22-062992.txt   64930
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Subject) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83043 | Film No.: 22703686
SIC: 2834 Pharmaceutical Preparations

Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G